Showing results (81-90 of 238) with videos related to
Sort By:
Pageof 24
Acta Diabetologica|January 31, 2021
Targeting of the diabetes prevention program leads to substantial benefits when capacity is constrainedNatalia Olchanski, David van Klaveren, Joshua T Cohen, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 15, 2011
Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal RegistryMartin Wagner, David Ansell, David M Kent, et al.Stroke|March 8, 2008
Benchmarks and determinants of adherence to stroke performance measuresJudith A Hinchey, Timothy Shephard, Sarah T Tonn, et al.Journal of General Internal Medicine|July 21, 2010
The empirical basis for determinations of medical futilityEzra Gabbay, Jose Calvo-Broce, Klemens B Meyer, et al.Trials|August 14, 2010
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposalDavid M Kent, Peter M Rothwell, John P A Ioannidis, et al.Journal of Neurosurgery. Spine|July 28, 2022
Lumbar stenosis due to wild-type transthyretin amyloid-induced thickening of the ligamentum flavum: a separate etiology from degeneration of intervertebral discs?Andy Y Wang, Matthew Kanter, Michelle Olmos, et al.Plos One|March 30, 2018
Clinicians' perspectives on incidentally discovered silent brain infarcts - A qualitative studyLester Y Leung, Paul K J Han, Christine Lundquist, et al.Journal of Clinical Epidemiology|October 16, 2004
Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarctionDavid M Kent, Sandeep Vijan, Rodney A Hayward, et al.NPJ Digital Medicine|March 29, 2023
A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databasesAlexandros Rekkas, David van Klaveren, Patrick B Ryan, et al.International Journal of Epidemiology|July 5, 2016
Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trialsDavid M Kent, Jason Nelson, Issa J Dahabreh, et al.Pageof 24